New insights for a therapeutic approach in glioblastoma

March 18, 2011, Friedrich Miescher Institute for Biomedical Research
New insights for a therapeutic approach in glioblastoma
High level of MNK1 protein (brown) in human glioblastoma.

(PhysOrg.com) -- Scientists from the Friedrich Miescher Institute for Biomedical Research have identified a new and important molecular player in glioblastoma. The amount of the MNK1 kinase is not only dramatically increased in this devastating brain tumor, but its inhibition reduces cell proliferation and substantially sensitizes glioma cells to rapamycin. MNK1 controls the production of cancer related proteins, in particular those highly activated in malignant tumors. Their results are published today in Cancer Research.

Glioblastoma multiforme (GBM) is one of the most deadly brain tumors; current treatment regimes can only abate the symptoms and prolong life for just one year. Scientists in Brian Hemmings' group at the Friedrich Miescher Institute for Biomedical Research together with colleagues from the University Hospital Basel have now identified and characterized a signaling pathway with therapeutic implications for deadly .

MNK1, or in full MAP kinase-interacting kinase 1, is a signaling molecule regulating other proteins by phosphorylation. In a study published online in , the FMI scientists found large amounts of the MNK1 protein in . Furthermore, the study showed that MNK1 inactivation reduced glioma cell growth. Finally, treatment with the MNK1 inhibitory compound CGP57380 (Novartis) together with rapamycin had a strong and additive cytostatic effect.

To further characterize the role of MNK1 in glioblastoma, the scientists analyzed MNK1-regulated events. MNK1 can associate with the translation machinery and regulates factors involved in via . Importantly, the cancer biologists identified a MNK1 signaling cascade that controls translation of cancer-related RNAs including SMAD2, a key component of the TGFß-signaling pathway, which is thought to play a crucial role in tumor malignancy. The study offers new insights into how MNK1 pathways contribute to brain tumour progression and recommends MNK1-controlled translational pathways for targeted strategies to more effectively treat glioblastoma.

"We believe that dissecting glioma signaling networks will not only explain principles underlying gliomagenesis or treatment resistance, but it will also propose novel molecular strategies for effective therapy." says Michal Grzmil, postdoctoral researcher in Brian Hemmings' laboratory and first author of the publication. "This is not to say that a treatment for glioblastoma is just around the corner. What we have done is the basic characterization of what we believe is an important signaling pathway in glioblastoma."

More information: Grzmil M, et al. (2011). MAP kinase-interacting kinase 1 (MNK1) regulates SMAD2-dependent TGFß singaling pathway in human glioblastoma. Cancer Res 71:2392. cancerres.aacrjournals.org/con … t/71/6/2392.abstract

Related Stories

Recommended for you

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.